NCT04447937

Immunodeficiency in MS

Analysis of Medical Therapy and History as Risks of Immunodeficiency in Multiple Sclerosis Patients

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 1,500 (estimated)
• Sponsor: Advanced Neurosciences Institute · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to identify if there is a relationship between multiple sclerosis disease-modifying therapy exposure, immunodeficiencies, and infection risk in subjects living with MS.

Detailed description

The purpose of this study is to identify if there is a relationship between multiple sclerosis disease-modifying therapy exposure, immunodeficiencies, and infection risk in subjects living with MS. By understanding this relationship future studies can be designed to create a model of immunosenescence in multiple sclerosis, which could help healthcare providers to predict and assess health risks. Preventative strategies can then be tested to look for ways to prevent these immune-related risks.

Conditions

• Multiple Sclerosis
• Hypogammaglobulinemia
• Immunodeficiency
• Infection, Bacterial

Interventions

Type	Name	Description
OTHER	No Interventions	There are no interventions associated with the study.

Timeline

• Start date: 2020-06-29
• Primary completion: 2021-01-30
• Completion: 2021-07-30
• First posted: 2020-06-25
• Last updated: 2020-06-25

Locations

1 site across 1 country: United States